Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 3/20 | 0.31 |
| ▸ | NOS3 | P29474 | 2/20 | 0.31 |
| ▸ | NOS1 | P29475 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26968700 | 0.80 | ALDH1A1 (0.34) | ALDH1A1LMNA | |
| SCHEMBL1421677 | 0.79 | ALDH1A1 (0.50) | ALDH1A1LMNASLC15A2FOLH1CYP1A2 | |
| SCHEMBL499963 | 0.78 | CHRM1 (0.46) | CYP1A2 | |
| SCHEMBL9569276 | 0.78 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL20680195 | 0.75 | CA2 (0.47) | CYP1A2 | |
| SCHEMBL9464835 | 0.75 | ALDH1A1 (0.45) | ALDH1A1LMNASLC15A2FOLH1CYP1A2 | |
| SCHEMBL166047 | 0.73 | MAPT (0.35) | CYP1A2 | |
| SCHEMBL10697627 | 0.72 | MAPT (0.55) | CYP1A2 | |
| SCHEMBL7147426 | 0.71 | LMNA (0.34) | ALDH1A1LMNACYP1A2 | |
| SCHEMBL15194246 | 0.70 | THRB (0.42) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158328-A1 | METHOD FOR PRODUCING CYCLOHEXENONE COMPOUND | API CORPORATION (JP) | 2024-05-16 | — | — | US | disclosed |
| EP-4296254-A1 | METHOD FOR PRODUCING CYCLOHEXENONE COMPOUND | API Corporation (JP) | 2023-12-27 | — | — | EP | disclosed |
| WO-2022176837-A1 | METHOD FOR PRODUCING CYCLOHEXENONE COMPOUND | 株式会社エーピーアイ コーポレーション | 2022-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240158328-A1 | METHOD FOR PRODUCING CYCLOHEXENONE COMPOUND | CYP4A11, HSD17B7, CYP51A1 | ALDH1A1 938/4885LMNA 1448/4885SLC15A2 4634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.